Effectiveness and safety of shortened intensive treatment for children with tuberculous meningitis (SURE): a protocol for a phase 3 randomised controlled trial evaluating 6 months of antituberculosis therapy and 8 weeks of aspirin in Asian and African children with tuberculous meningitis

Effectiveness and safety of shortened intensive treatment for children with tuberculous meningitis (SURE): a protocol for a phase 3 randomised controlled trial evaluating 6 months of antituberculosis therapy and 8 weeks of aspirin in Asian and African children with tuberculous meningitis

Introduction Childhood tuberculous meningitis (TBM) is a devastating disease. The long-standing WHO recommendation for treatment is 2 months of intensive phase with isoniazid (H), rifampicin (R), pyrazinamide (Z) and ethambutol (E), followed by 10 months of isoniazid and rifampicin. In 2022, WHO rel...

Full description

Saved in:
Bibliographic Details
Main Authors: Varinder Singh, Naveen Sankhyan, Diana M Gibb, Guy E Thwaites, Hilda Mujuru, James A Seddon, Nitya Wadhwa, Angela Crook, Evelyne Kestelyn, Julie Huynh, Suzanne T Anderson, Nhung Nguyen, Thanh Nguyen, Anna Turkova, Kafula Lisa Nkole, Elena Frangou, Nguyen Viet Nhung, Godfrey Musoro, Chishala Chabala, Kusum Nathoo, Ennie Chidziva, Moses Chitsamatanga, Suvasini Sharma, Phuc Huu Phan, Louise Choo, Tung Huu Trinh, Titiksha Sirari, Constantine Mutata, Anna Griffiths, Eric Wobudeya, Caitlin Muller, Sierra Santana, Lam Van Nguyen, Dai Tran, Susan Abarca-Salazar, Robin Basu-Roy, Sibusiswe Wesa, Vivian Mumbrio, Misheck Phiri, Joyce Chipili Lungu, Christina Zulu, Kriti Nautiyal, Kamal Singhal, Joshua Choga, Secrecy Gondo, Adam Gregory, Yogesh Kumar Tiwari, Mutsa Bwakura, Diksha Shafiq, Ngoc Lam Hong Bao, Shepard Mudzingwa, Nancy Nabukeera
Format: Article
Language:English
Published: BMJ Publishing Group 2025-04-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/15/4/e088543.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items